BioPharmSignal logoBioPharmSignal

Biotech News

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Hyperfine (HYPR)HyperfineEarnings

GUILFORD, Conn. --(BUSINESS WIRE)--Mar. 5, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial

Related news

HYPRHyperfine2026-07-23 20:05 EST

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

HYPRHyperfine2026-08-06 20:05 EST

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

ANGOAngioDynamics2026-07-14 10:00 EST

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability

ANGOAngioDynamics2026-06-30 12:00 EST

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026

XAIRBeyond Air2026-06-26 11:00 EST

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

ACHCAcadia Healthcare2026-07-28 20:05 EST

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

ATRCAtriCure2026-07-02 12:00 EST

AtriCure to Announce Second Quarter 2026 Financial Results

FEMYFEMASYS2026-08-14 20:05 EST

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

PAVMPAVmed2026-08-14 12:00 EST

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

View all latest news

Hyperfine

Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...

Recent company news

HYPRHyperfine2026-08-20 12:15 EST

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

HYPRHyperfine2026-08-06 20:05 EST

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

HYPRHyperfine2026-07-30 12:15 EST

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

HYPRHyperfine2026-07-23 20:05 EST

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

HYPRHyperfine2026-07-01 12:15 EST

Hyperfine Announces European Launch of Next-Generation Swoop® System

Stock data

Close
0.90 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States